Bibliography
Found 257 results
Filters: Keyword is HIV Infections [Clear All Filters]
Age, cognitive status, and accuracy of ADL self-reports in adults living with HIV. AIDS Care. 2023 ;35(2):289-295.
. Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology. J Infect Dis. 2023 ;227(Suppl 1):S3-S15.
. Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy. J Clin Invest. 2023 ;133(12).
Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states. J Neurovirol. 2023 ;29(3):337-345.
. Evaluation of Archival HIV DNA in Brain and Lymphoid Tissues. J Virol. 2023 ;97(6):e0054323.
Microbial molecule ingress promotes neuroinflammation and brain CCR5 expression in persons with HIV-associated neurocognitive disorders. Brain Behav Immun. 2023 ;107:110-123.
Microglia proliferation underlies synaptic dysfunction in the prefrontal cortex: implications for the pathogenesis of HIV-1-associated neurocognitive and affective alterations. J Neurovirol. 2023 ;29(4):460-471.
. Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV. AIDS. 2023 ;37(8):1247-1256.
. Neuropsychiatric predictors of cognitive functioning over a one-year follow-up period in HIV. J Affect Disord. 2023 ;336:92-96.
. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023 ;37(14):2137-2147.
. Physical and Mental Health Screening in a New York City HIV Cohort During the COVID-19 Pandemic: A Preliminary Report. J Acquir Immune Defic Syndr. 2021 ;86(3):e54-e60.
. . Assessing Cognitive Functioning in People Living With HIV (PLWH): Factor Analytic Results From CHARTER and NNTC Cohorts. J Acquir Immune Defic Syndr. 2020 ;83(3):251-259.
. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2020 ;83(1):56-64.
. Circulating levels of ATP is a biomarker of HIV cognitive impairment. EBioMedicine. 2020 ;51:102503.
. Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system. AIDS. 2020 ;34(13):1975-1977.
. HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis. PLoS Biol. 2020 ;18(5):e3000660.
. Age of Last Alcohol Use Disorder Relates to Processing Speed Among Older Adults Living with HIV. Alcohol Alcohol. 2019 ;54(2):139-147.
. Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral Reservoirs. Antimicrob Agents Chemother. 2019 ;64(1).
Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults. J Neurovirol. 2019 ;25(6):741-753.
. Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2019 ;82(5):475-482.
. Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 ;33(15):2309-2316.
. Blood-brain barrier pericytes as a target for HIV-1 infection. Brain. 2019 ;142(3):502-511.
. Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient Cohort. Arterioscler Thromb Vasc Biol. 2019 ;39(9):1762-1775.
.